Azenta, Inc. (BA3.F)

50,50 +0,70 (+1,41%) Börsenschluss: 04:08PM CEST

Azenta, Inc.

200 Summit Drive
Burlington, MA 01803
United States
978 262 2626
https://www.azenta.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 3.500

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Stephen S. Schwartz	CEO, President & Director	978,95k	N/A	1959
Mr. Robin Vacha	Senior Vice President of Global Operations	495,17k	N/A	1976
Mr. Jason W. Joseph	Senior VP, General Counsel & Corporate Secretary	505,18k	N/A	1971
Mr. Herman Cueto	Executive VP & CFO	N/A	N/A	1974
Ms. Violetta Hughes	VP & Chief Accounting Officer	N/A	N/A	1972
Mr. Michael Paulo	VP and Chief Information & Digital Officer	N/A	N/A	N/A
Mr. John E. O'Brien	Senior Vice President of Corporate Development	N/A	N/A	1970
Ms. Olga Pirogova	Senior VP & Chief HR Officer	N/A	N/A	1974
Mr. J. Robert Woodward	Senior Vice President of Global Quality & Regulatory	N/A	N/A	N/A
Dr. Ginger Zhou Ph.D.	Senior VP & GM of Multiomics and Synthesis Solutions	N/A	N/A	1977

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Corporate Governance

Azenta, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 4. Die grundlegenden Scores sind Audit: 8, Vorstand: 2, Shareholderrechte: 6, Kompensation: 3.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.